Ventana Clinical Research Corporation   Report issue

For profit Phase 1 Phase 3
Founded: San Ramon CA United States (2000)
Status: No NME R&D (2000)

Organization Overview

First Clinical Trial
2003
NCT00794209
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Alternative names

Ventana Clinical Research Organization

Active Ingredients

Drugs in Phase 3 Trials (1)

voclosporin (Lupkynis) (2 trials)

Drugs in Phase 1 Trials (2)

fentanyl (Innovar) (1 trial)

methylphenidate (ritalin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Psoriasis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 3